Merck, CLS354230-1EA, Corning®Matrigel®Growth Factor Reduced (GFR) Basement Membrane Matrix

General description
Corning Matrigel Growth Factor Reduced (GFR) Basement Membrane Matrix, 10 mL, is suited for applications requiring a highly defined basement membrane preparation. Available in standard GFR, High Concentration (HC), and Phenol Red-free formats. Corning Matrigel matrix is a solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins, including Laminin (a major component), Collagen IV, heparan sulfate proteoglycans, entactin/nidogen, and a number of growth factors.

Quality

Mouse colonies routinely screened for pathogens via Mouse Antibody Production (MAP) testing
Extensive PCR testing performed to screen for a number of pathogensTested and found negative for bacteria, fungi, and mycoplasma
Protein concentrations determined by Lowry method
Endotoxin units measured by Limulus Amoebocyte Lysate assay
Gel stability tested for a period of 14 days at 37°C
Biological activity determined for each lot using neurite outgrowth assay.
Source
EHS mouse tumor

Application

Cell Growth and Differentiation
Metabolism/Toxicology Studies
Invasion Assays
in vitro and in vivo Angiogenesis Assays
in vivo Angiogenesis Studies and Augmentation of Tumors in Immunosuppressed Mice
Preparation and Storage
Store at -20°C. Avoid multiple freeze-thaws.

Click here for Corning Matrigel Lot Selection and Reservation.

For Customers in California only: WARNING Please refer to Safety Data Sheet (SDS) Section 15 or Letter in Lieu for more information regarding California Proposition 65.
Legal Information
Corning is a registered trademark of Corning, Inc.
Matrigel is a registered trademark of Corning, Inc.